The Past, Present & Future of Naltrexone: An Expert Discussion
Naltrexone has been approved for the treatment of alcohol problems since 1994. But it is prescribed to less than 3% of people with Alcohol Use Disorder.
In this panel discussion, leading experts explain the research that proved naltrexone helps people drink less or quit and describe the barriers to its adoption.
They also answer common questions about naltrexone — how it works, when to take it, how to manage side effects, and how to work with your healthcare professional to get the best results from the medication.
Panelists include:
· Dr. Joseph Volpicelli, M.D., Ph.D., Executive Director of The Institute of Addiction Medicine and Medical Director at the Volpicelli Center
· Percy Menzies, President of Assisted Recovery Centers of America
· Dr. Joshua D. Lee, M.D., Professor of Population Health and Medicine at the NYU Grossman School of Medicine and Chief Clinical Adviser to Oar Health
The panel is moderated by Jonathan Hunt-Glassman, Oar Health CEO.
